'People will very rapidly spit into a cup and send it to 23andMe... and guess what? Their DNA is now owned by a private company.'
It's also worth noting that given the popularity of these platforms, it's quite difficult to opt out — even if you don't choose to partake, your relatives might, which can haveStill, whether these terrifying weapons are genuinely in development, the lawmaker's claims are cause to more deeply examine our relationship to our most personal data — which, as Crow additionally warned, are already perhaps too lax.
"You can't have a discussion about this without talking about privacy and the protection of commercial data because expectations of privacy have degraded over the last 20 years," said the rep,. "Young folks actually have very little expectation of privacy, that's what the polling and the data show." Crow's comments are certainly unsettling. In truth, there's only so much we can do, but it's true that data protection — especially when it comes to information so incredibly personal — is always something that deserves our attention. It's easy to get jaded, but we implore you: read the fine print.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Ancient DNA Illuminates the History of Horses in the AmericasOne of the oldest-known specimens points to the Iberian Peninsula as the source of the first domesticated horses in the Americas.
Read more »
Recording gene expression order in DNA by CRISPR addition of retron barcodes - NatureRetro-Cascorder, a system for time-ordered recording of transcriptional output, uses retrons as a tag to mediate DNA barcode acquisition in a CRISPR array.
Read more »
How DNA and Training Impact Athletic BuildResearch says between swimming, sprinting and other sports, athletic build can play a large role in an athlete's success.
Read more »
Detecting cell-of-origin and cancer-specific methylation features of cell-free DNA from Nanopore sequencing - Genome BiologyThe Oxford Nanopore (ONT) platform provides portable and rapid genome sequencing, and its ability to natively profile DNA methylation without complex sample processing is attractive for point-of-care real-time sequencing. We recently demonstrated ONT shallow whole-genome sequencing to detect copy number alterations (CNAs) from the circulating tumor DNA (ctDNA) of cancer patients. Here, we show that cell type and cancer-specific methylation changes can also be detected, as well as cancer-associated fragmentation signatures. This feasibility study suggests that ONT shallow WGS could be a powerful tool for liquid biopsy. Graphical Abstract
Read more »